Foreign-invested pharmaceutical firms turn to aggressive marketing

Published: 2002-07-29 06:59:00

Updated: 2002-07-29 06:59:00

Foreign-invested pharmaceutical firms are employing aggressive marketing tactics in a bid to take the leading position in the domestic pharmaceutical market within thee years with their new products.

Janssen Korea is hoping to take the first position with three new products including Triclest...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK